Nathanael R. Fillmore
Topics / Clinical Oncology
Topic

Clinical Oncology

Fillmore and his collaborators focus on optimizing oncologic care through the integration of large-scale data analytics and the refinement of prostate cancer surveillance strategies. His work includes the development of Learning Health System infrastructure to translate real-world data into clinical decision-making and the use of sentiment analysis to monitor patient experiences in lung cancer. Additionally, his research evaluates the efficacy of active surveillance for prostate cancer, demonstrating the limitations of magnetic resonance imaging in replacing confirmatory biopsies to avoid the underdiagnosis of high-grade disease.

U.S. Veterans and VA Data 4 Electronic Health Records 3 Active Surveillance 2 Confirmatory Biopsy 2 Prostate Cancer 2 Race and Ethnicity 2 Real World Evidence 2 Retrospective Cohort Study 2 Natural Language Processing 2 Age Factors 1 Area Deprivation Index 1 Clinical Practice Diffusion 1

Publications (4)

2026

Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.

Matthew R. Cooperberg†, John R. Bihn†, John M. Culnan, Jennifer La, Sergey D. Goryachev, Daniel C. R. Chen, Oleg Soloviev, Grace Lee, June K. Corrigan, Kaitlin N. Swinnerton, Nicholas G. Nickols, Karlynn N. Dulberger, Pedro Barata, Rhonda L. Bitting, Mary T. Brophy, Heather H. Cheng, Hoedt Amanda De, Nhan V. Do, Stephen J. Freedland, Isla P. Garraway, J. Michael Gaziano, Susan Halabi, Richard L. Hauger, Stacy Loeb, David M. Nanus, Timothy R. Rebbeck, Matthew B. Rettig, Chong-Xian Pan, Kenute Myrie, Rachel B. Ramoni, Nathanael R. Fillmore‡, Channing J. Paller‡† Equal first authorship · ‡ Equal senior authorship

JAMA Oncology12(1), 111-113
U.S. Veterans and VA Data Retrospective Cohort Study Electronic Health Records Prostate Cancer Active Surveillance